Jennifer Haller is a Seattle woman who volunteered for the first time testing an experimental vaccine that was developed to help prevent the coronavirus.
She received the first of two injections on 16 March. The medical examination is being conducted at Seattle’s Kaiser Permanente Washington Health Research Institute. Researchers recruited 45 healthy individuals to participate in the first phase of the trial, which was funded by the National Institutes of Health.
Haller has a bachelor’s degree in communications from the University of Washington.
Husband & Children
Jennifer Haller lives with her husband and two teenagers in Seattle, one of the first hotspots of the coronavirus in the United States.
According to her LinkedIn page, she also is an animal rescuer. Haller says she fosters “special-needs dogs during their transition from high-kill shelters in CA and TX to their forever homes in Seattle.”
According to her Facebook page, Haller is also the co-founder of a consulting firm called The Flight Team. The company works primarily with tech start-ups.
Haller works at a tech company called Attunely Inc as an operations manager. She praised the company’s website as a “battle-tested operations professional” with a “special passion for helping tech companies establish their unique culture and fostering workplace environments where employees feel comfortable and valued.”
Haller is First Seattle Woman who Try COVID-19 Vaccine
The phase 1 study aims to test three different doses of the mRNA-1273 vaccine ad hopes to recruit 45 healthy adults for the initial trial. Participants will receive two shots of the vaccine, 28 days apart and will be monitored to evaluate both the safety and immunogenicity of the vaccine. The latter involves seeing how well the vaccine stimulates an immune response to a protein on the SARS-CoV2 coronavirus surface.
The first person to get the vaccine was 43-year old Jennifer Haller from Seattle who said; “I hope that we get to a working vaccine quickly and that we can save lives and people can go back to life as soon as possible,” in an interview with TIME.
Medical professionals developed and produced the experimental vaccine at record-breaking speed as the coronavirus spread rapidly around the world. The National Institutes of Health says scientists were able to learn from past studies of similar coronavirus strains.
NIAID Director Anthony Fauci has praised the team’s work. “Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority. This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”
A new phase 1 clinical trial of a potential vaccine for the SARS-CoV2 coronavirus began on Monday in Seattle, with the first person to enroll in the trial receiving the vaccine.
The vaccine, mRNA-1273, was developed by biotechnology company Moderna in combination with researchers from the National Institutes of Health (NIH). The trial is being conducted at Kaiser Permanente Washington Health Research Institute in Seattle.
Our (co-inventors @McLellan_Lab) COVID-19 vaccine (spike delivered by @moderna_tx‘s mRNA) was just injected into the 1st human in phase 1 trial, only 66 days after viral sequence release… a testament to rapid vaccine development for emerging diseases🦠💚https://t.co/2DLZsdirAD
Haller said she felt privileged to be in a position to help. “I’m healthy. I have a full-time salary job, my company is flexible, and they allow me to take time off to do this. I have the support of friends and family. My real concern is for the people that have hourly jobs, that lives are going to be severely impacted coming up soon.”